Drug discovery services relating to ophthalmic diseases and disorders; drug discovery services relating to diabetic macular edema; drug discovery services relating to angioedema; drug discovery services relating to hereditary angioedema; drug discovery services relating to diseases and disorders mediated by the contact activation system; drug discovery services relating to plasma kallikrein or fac Read More

Classification Information

Class [044]
Medical, Beauty & Agricultural Services

Medical and healthcare services relating to ophthalmic diseases and disorders; medical and health care services relating to diabetic macular edema; medical and healthcare services relating to angioedema; medical and healthcare services relating to hereditary angioedema; medical and healthcare services relating to diseases and disorders mediated by the contact activation system; medical and healthcare services relating to plasma kallikrein or factor XIIa mediated diseases or disorders

Class [042]
Computer & Software Services & Scientific Services

Class [010]
Medical Instrument Products

Medical and surgical instruments and apparatus for use in the treatment of ophthalmic diseases and disorders, diabetic macular edema, angioedema, hereditary angioedema, diseases and disorders mediated by the contact activation system, and plasma kallikrein or factor XIIa mediated diseases or disorders; drug delivery devices for use in the treatment of ophthalmic diseases and disorders, diabetic macular edema, angioedema, hereditary angioedema, diseases and disorders mediated by the contact activation system, and plasma kallikrein or factor XIIa mediated diseases or disorders

Class [005]
Pharmaceutical Products

Pharmaceutical preparations for the treatment of ophthalmic diseases and disorders; pharmaceutical preparations for the treatment of diabetic macular edema; pharmaceutical preparations for the treatment of angioedema; pharmaceutical preparations for the treatment of hereditary angioedema; pharmaceutical preparations for the treatment of diseases and disorders mediated by the contact activation system; pharmaceutical preparations for the treatment of plasma kallikrein or factor XIIa mediated diseases or disorders

Mark Details

Serial Number

No 79351011

Mark Type

No Service Mark

Attorney Docket Number

44D Filed

44D Current

44E filed

44E Current

66A Filed

Yes

66A Current

Yes

Current Basis

No Basis

Legal History

Status Date	Action Taken
23^rd Oct 2023	NOTIFICATION PROCESSED BY IB
29^th Sep 2023	FINAL DISPOSITION PROCESSED
29^th Sep 2023	FINAL DISPOSITION NOTICE SENT TO IB
28^th Sep 2023	GRANT OF PROTECTION CREATED, TO BE SENT TO IB
29^th Aug 2023	REGISTERED-PRINCIPAL REGISTER
13^th Jun 2023	PUBLISHED FOR OPPOSITION
24^th May 2023	NOTICE OF PUBLICATION
06^th May 2023	APPROVED FOR PUB - PRINCIPAL REGISTER
05^th May 2023	ASSIGNED TO EXAMINER
04^th Oct 2022	APPLICATION FILING RECEIPT MAILED

KALVISTA